Angiogenesis during post-stroke neurovascular recovery is linked to oligodendrocyte precursor cells (OPCs) phenotypic shifts. Oridonin, a natural diterpenoid, has the potential to regulate post-stroke angiogenesis, but its specific mechanism remains unclear. Intraperitoneal injection of oridonin significantly promoted angiogenesis in the ischemic penumbra of stroke model mice. However, endothelial cell proliferation, sprouting, and tube formation assays demonstrated that oridonin exerted no direct regulatory effect on endothelial cell-triggered angiogenesis in vitro. Unexpectedly, oridonin notably promoted perivascular OPCs proliferation in the ischemic penumbra and enhanced the secretion of the pro-angiogenic factor Wnt7a by immunofluorescence staining and enzyme-linked immunosorbent assay (ELISA) analysis. Meanwhile, the conditioned medium from oridonin-treated OPCs enhanced the angiogenic effect of endothelial cells, which was reversed by inhibition of the Wnt7a/β-catenin pathway. Mechanistically, drug affinity responsive target stability (DARTS) and microscale thermophoresis (MST) assays confirmed that oridonin directly bound to α-ketoglutarate-dependent prolyl hydroxylase 2 (PHD2), thereby inhibiting the ubiquitination and degradation of hypoxia-inducible factor 1-alpha (HIF-1α) in OPCs and regulating their proliferation and pro-angiogenic effects. Collectively, oridonin targets PHD2 to inhibit HIF-1α ubiquitination and degradation in OPCs, thereby facilitating OPC proliferation and activating the Wnt7a/β-catenin pathway to promote endothelial angiogenesis after stroke.
FeiginVLForouzanfarMHKrishnamurthiR, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet2014; 383: 245–254.
3.
FeskeSK.Ischemic stroke. Am J Med2021; 134: 1457–1464.
4.
ShehjarFMaktabiBRahmanZA, et al. Stroke: molecular mechanisms and therapies: update on recent developments. Neurochem Int2023; 162: 105458.
5.
WangRXShaoYYangX, et al. The effect of Tianjiang Xueshuantong Wan pills on ischemia–reperfusion injury after thrombolysis in acute cerebral infarction. Explore2023; 19: 48–51.
6.
SchaefferSIadecolaC.Revisiting the neurovascular unit. Nat Neurosci2021; 24: 1198–1209.
7.
LinT-NSunS-WCheungW-M, et al. Dynamic changes in cerebral blood flow and angiogenesis after transient focal cerebral ischemia in rats. Evaluation with serial magnetic resonance imaging. Stroke2002; 33: 2985–2991.
8.
KrupinskiJKaluzaJKumarP, et al. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke1994; 25: 1794–1798.
9.
SaberHLiebeskindDS.Infarct progression in the early and late phases of acute ischemic stroke. Neurology2021; 97: S60–S67.
10.
WangJXiongTWuQ, et al. Integrated strategies for targeting arteriogenesis and angiogenesis after stroke. Transl Stroke Res2025; 16: 1383–1399.
11.
ChavaliMUlloa-NavasMJPérez-BorredáP, et al. Wnt-dependent oligodendroglial–endothelial interactions regulate white matter vascularization and attenuate injury. Neuron2020; 108: 1130–1145.e5.
12.
TsaiH-HNiuJMunjiR, et al. Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science2016; 351: 379–384.
13.
XuSLuJShaoA, et al. Glial cells: role of the immune response in ischemic stroke. Front Immunol2020; 11: 294.
14.
WangL-PPanJLiY, et al. Oligodendrocyte precursor cell transplantation promotes angiogenesis and remyelination via Wnt/β-catenin pathway in a mouse model of middle cerebral artery occlusion. J Cereb Blood Flow Metab2022; 42: 757–770.
15.
ChengWHuangCMaW, et al. Recent development of oridonin derivatives with diverse pharmacological activities. Mini rev Med Chem2019; 19: 114–124.
16.
HeHJiangHChenY, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun2018; 9: 2550.
17.
LiLChengS-QGuoW, et al. Oridonin prevents oxidative stress-induced endothelial injury via promoting Nrf-2 pathway in ischaemic stroke. J Cell Mol Med2021; 25: 9753–9766.
18.
ZhangMHouLTangW, et al. Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4/PPARγ signalling. J Cell Mol Med2023; 27: 4155–4170.
19.
LongaEZWeinsteinPRCarlsonS, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke1989; 20: 84–91.
20.
ZhaoYZhuWWanT, et al. Vascular endothelium deploys caveolin-1 to regulate oligodendrogenesis after chronic cerebral ischemia in mice. Nat Commun2022; 13: 6813.
21.
BaoYGuoXWangJ, et al. Exploring core genes involved in ischemic stroke and the therapeutic potential of hyperbaric oxygen: insights from transcriptomic analysis. Neuromol Med2025; 27: 54.
22.
ChenYBalasubramaniyanVPengJ, et al. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc2007; 2: 1044–1051.
23.
LiuXYeQHuangZ, et al. BAG3 overexpression attenuates ischemic stroke injury by activating autophagy and inhibiting apoptosis. Stroke2023; 54: 2114–2125.
24.
SunPZhangKHassanSH, et al. Endothelium-targeted deletion of microRNA-15a/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery. Circ Res2020; 126: 1040–1057.
25.
WangCDaiXWuS, et al. FUNDC1-dependent mitochondria-associated endoplasmic reticulum membranes are involved in angiogenesis and neoangiogenesis. Nat Commun2021; 12: 2616.
26.
RenY-SLiH-LPiaoX-H, et al. Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: principles and application. Biochem Pharmacol2021; 194: 114798.
27.
ChengCLiuKZhangJ, et al. Ginsenoside CK targets PHD2 to prevent platelet adhesion and enhance blood circulation by modifying the three-dimensional arrangement of collagen. Acta Pharm Sin B2025; 15: 1497–1513.
28.
ChenY-CWuJ-SYangS-T, et al. Stroke, angiogenesis and phytochemicals. Front Biosci (Schol Ed)2012; 4: 599–610.
29.
FangJWangZMiaoC-Y.Angiogenesis after ischemic stroke. Acta Pharmacol Sin2023; 44: 1305–1321.
30.
HuangWBhaduriAVelmeshevD, et al. Origins and proliferative states of human oligodendrocyte precursor cells. Cell2020; 182: 594–608.e11.
31.
TanakaKNogawaSItoD, et al. Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain. Neuroreport2001; 12: 2169–2174.
32.
KishidaNMakiTTakagiY, et al. Role of perivascular oligodendrocyte precursor cells in angiogenesis after brain ischemia. J Am Heart Assoc2019; 8: Article e011824.
33.
PengZPangHWuH, et al. CCL2 promotes proliferation, migration and angiogenesis through the MAPK/ERK1/2/MMP9, PI3K/AKT, Wnt/β‑catenin signaling pathways in HUVECs. Exp Ther Med2023; 25: 77.
34.
SongSHuangHGuanX, et al. Activation of endothelial Wnt/β-catenin signaling by protective astrocytes repairs BBB damage in ischemic stroke. Prog Neurobiol2021; 199: 101963.
35.
WlodarczykJLengAAbadchiSN, et al. Transfection of hypoxia-inducible factor-1α mRNA upregulates the expression of genes encoding angiogenic growth factors. Sci Rep2024; 14: 6738.
36.
YangZHuangYZhuL, et al. SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1α and reactive oxygen species. Cell Death Dis2021; 12: 77.
37.
YuenTJSilbereisJCGriveauA, et al. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell2014; 158: 383–396.
38.
ShenXLiMWangC, et al. Hypoxia is fine-tuned by Hif-1α and regulates mesendoderm differentiation through the Wnt/β-catenin pathway. BMC Biol2022; 20: 219.
39.
XuLHuanLGuoT, et al. LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α. Oncogene2020; 39: 7005–7018.
40.
LiuXDengHTangJ, et al. OTUB1 augments hypoxia signaling via its non-canonical ubiquitination inhibition of HIF-1α during hypoxia adaptation. Cell Death Dis2022; 13: 560.
41.
SunHLingSZhaoD, et al. Ginsenoside Re treatment attenuates myocardial hypoxia/reoxygenation injury by inhibiting HIF-1α ubiquitination. Front Pharmacol2020; 11: 532041.
42.
GongWHuiWQiaoS, et al. Brain and liver dual-targeting oridonin nanoparticles to enhance Aβ clearance for Alzheimer’s disease therapy. Adv Sci2026: Article e23458.
43.
LiangLWangHHuY, et al. Oridonin relieves depressive-like behaviors by inhibiting neuroinflammation and autophagy impairment in rats subjected to chronic unpredictable mild stress. Phytother Res2022; 36: 3335–3351.
44.
ZhaoXJZhuHYWangXL, et al. Oridonin ameliorates traumatic brain injury-induced neurological damage by improving mitochondrial function and antioxidant capacity and suppressing neuroinflammation through the Nrf2 pathway. J Neurotrauma2022; 39: 530–543.
45.
HatakeyamaMNinomiyaIKanazawaM.Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regener Res2020; 15: 16–19.
46.
ParoMRChakrabortyARAngeloS, et al. Molecular mediators of angiogenesis and neurogenesis after ischemic stroke. Rev Neurosci2023; 34: 425–442.
47.
JiangLShenFDegosV, et al. Oligogenesis and oligodendrocyte progenitor maturation vary in different brain regions and partially correlate with local angiogenesis after ischemic stroke. Transl Stroke Res2011; 2: 366–375.
48.
NiuJTsaiH-HHoiKK, et al. Aberrant oligodendroglial–vascular interactions disrupt the blood–brain barrier, triggering CNS inflammation. Nat Neurosci2019; 22: 709–718.
49.
JiangJZhangNSongH, et al. Oridonin alleviates the inhibitory effect of lipopolysaccharide on the proliferation and osteogenic potential of periodontal ligament stem cells by inhibiting endoplasmic reticulum stress and NF-κB/NLRP3 inflammasome signaling. BMC Oral health2023; 23: 137.
50.
SuYWangXYangY, et al. Astrocyte endfoot formation controls the termination of oligodendrocyte precursor cell perivascular migration during development. Neuron2023; 111: 190–201.e8.
51.
MadaiSKilicPSchmidtRM, et al. Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism. Theranostics2024; 14: 2856–2880.
52.
YangJZhangLErbelPJA, et al. Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor. J Biol Chem2005; 280: 36047–36054.
53.
NiJZhangQJiangL, et al. Catalpol regulates apoptosis and proliferation of endothelial cell via activating HIF-1α/VEGF signaling pathway. Sci Rep2024; 14: 28327.
54.
SeoJJeongDWParkJW, et al. Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun Biol2020; 3: 638.
55.
AprelikovaOChandramouliGVRWoodM, et al. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem2004; 92: 491–501.
56.
BonhamCAKuehlmannBGurtnerGC.Impaired neovascularization in aging. Adv Wound Care2020; 9: 111–126.
57.
JaakkolaPMoleDRTianYM, et al. Targeting of HIF-alpha to the von Hippel–Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science2001; 292: 468–472.
58.
BuckleyDLVan MolleIGareissPC, et al. Targeting the von Hippel–Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction. J Am Chem Soc2012; 134: 4465–4468.
59.
PaltoglouSRobertsBJ.HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases. Oncogene2007; 26: 604–609.
60.
LiCWangQShenS, et al. Oridonin inhibits VEGF-A-associated angiogenesis and epithelial-mesenchymal transition of breast cancer in vitro and in vivo. Oncol Lett2018; 16: 2289–2298.
61.
ZhouJLiYShiX, et al. Oridonin inhibits tumor angiogenesis and induces vessel normalization in experimental colon cancer. J Cancer2021; 12: 3257–3264.
62.
HeoDKimAANeumannB, et al. Transcriptional profiles of mouse oligodendrocyte precursor cells across the lifespan. Nat Aging2025; 5: 675–690.
63.
JanowskaJZiemka-NaleczMSypeckaJ.Inhibition of the HIF-1α signaling pathway promotes oligodendrocyte maturation in the in vitro model of perinatal asphyxia. Mol Neurobiol2025; 62: 15928–15942.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
